Finance

Beta
Lists
BEI:ETR
Beiersdorf AG
€67.56
+0.39%
(+0.26) 1D
Jun 4, 5:36:12 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BEI...
Open
€67.50
High
€68.30
Low
€67.08
Mkt. cap
16.29B
Avg. vol.
477.60K
Volume
308.36K
Dividend
1.48%
Quarterly dividend
€0.25
Ex-dividend date
Apr 22, 2025
P/E ratio
15.90
52-wk high
€120.10
52-wk low
€67.08
EPS
€4.25
Shares outstanding
241.10M
No. of employees
22K
Open
€67.50
High
€68.30
Low
€67.08
Mkt. cap
16.29B
Avg. vol.
477.60K
Volume
308.36K
Dividend
1.48%
Quarterly dividend
€0.25
Ex-dividend date
Apr 22, 2025
P/E ratio
15.90
52-wk high
€120.10
52-wk low
€67.08
EPS
€4.25
Shares outstanding
241.10M
No. of employees
22K
Analyst outlook
Analyst Ratings
Based on 12 analysts giving stock ratings to BEI in the past 3 months
Hold
Buy
3
Hold
7
Sell
2
12 month forecast
Based on 12 Wall Street analysts offering 12 month price targets for BEI in the last 3 months.
Highest
Current €67.56
€105.00 (+55.42%)
Average
€85.73 (+26.89%)
Lowest
€68.00 (+0.65%)
News stories
From sources across the web
Profile
Beiersdorf AG is a German multinational company that manufactures personal-care products and pressure-sensitive adhesives headquartered in Hamburg, Germany. Its brands include Elastoplast, Eucerin, Aquaphor, Labello, La Prairie, Nivea, Coppertone and Tesa. Although its shares are publicly listed, Beiersdorf is controlled by Maxingvest AG, which directly owns 50.49% of shares. Wikipedia
About Beiersdorf AG
CEOVincent Warnery
Employees21.6K
FoundedMar 28, 1882
HeadquartersHamburg, Hamburg, Germany
SectorPersonal care products
Websitebeiersdorf.com
Last report
Apr 21, 2026
Fiscal period
Q1 2026
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
2.48B / 2.53B
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.59B
2.59B
2.33B
2.33B
Cost of goods sold
1.05B
1.05B
1.03B
1.03B
Cost of revenue
1.05B
1.05B
1.03B
1.03B
Research and development expenses
92.00M
92.00M
90.50M
90.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.05B
1.05B
981.50M
981.50M
Operating expense
1.12B
1.12B
1.04B
1.04B
Total operating expenses
2.18B
2.18B
2.07B
2.07B
Operating income
415.50M
415.50M
261.50M
261.50M
Other non operating income
-4.00M
-4.00M
6.50M
6.50M
EBT including unusual items
408.50M
408.50M
265.50M
265.50M
EBT excluding unusual items
418.50M
418.50M
278.50M
278.50M
Income tax expense
128.00M
128.00M
68.50M
68.50M
Effective tax rate
31.33%
31.33%
25.80%
25.80%
Other operating expenses
-14.50M
-14.50M
-30.50M
-30.50M
Net income
276.00M
276.00M
193.50M
193.50M
Net profit margin
10.64%
10.64%
8.30%
8.30%
Earnings per share
-
-
-
-
Interest and investment income
14.50M
14.50M
14.00M
14.00M
Interest expense
-7.50M
-7.50M
-4.50M
-4.50M
Net interest expenses
7.00M
7.00M
9.50M
9.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
489.50M
489.50M
314.00M
314.00M
Gain or loss from assets sale
1.00M
1.00M
3.00M
3.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer